All articles tagged with #wolbachia
President Trump signed an executive order mandating a 90% reduction in invasive mosquito populations and a 50% cut in ticks in Washington, D.C., by 2028. The directive tasks the EPA with fast-tracking approvals for bioengineered control methods, including genetic modification and sterilization techniques, while HHS is authorized to launch prize competitions for disease treatments.
A novel biological mosquito control strategy has been introduced in the Washington, D.C., and Maryland area. This summer, a pest control company released 600,000 male mosquitoes infected with the naturally occurring bacterium Wolbachia across 25 properties. The goal is to reduce mosquito populations by preventing eggs from hatching when these males mate with wild females. Early results from one homeowner in Silver Spring, Maryland, suggest a noticeable decrease in biting insects, marking the first time this specific treatment has been deployed in the region.
In the San Gabriel Valley, California, officials are releasing nearly 500,000 sterile male mosquitoes weekly to reduce disease-carrying populations. This strategy uses the Wolbachia bacterium to prevent reproduction, addressing a longer mosquito season caused by climate change. While droughts have reduced mosquito numbers elsewhere in the US, warmer temperatures are extending breeding seasons and increasing the risk of dengue and other vector-borne diseases globally.
Google has filed for an EPA experimental-use permit to release up to 64 million Wolbachia-treated male mosquitoes across Florida and California over two years to reduce disease transmission and mosquito populations without pesticides; the EPA has not yet approved the plan, public comments closed on June 5, 2026, and opponents warn about ecological risks and no built‑in rollback, while supporters call it a targeted, pesticide-free vector-control tool.
About 600,000 Wolbachia-infected, non-biting male mosquitoes are being released across the DC area this summer to curb local populations; when they mate with wild females, the Wolbachia bacteria prevents eggs from hatching, reducing future generations. Bee Safe Mosquito Control is the first US company to offer this directly to residents, and broader interest is growing, with Alphabet seeking approval to release up to 64 million such mosquitoes in California and Florida amid rising mosquito pressures from climate change.
Australian field trials releasing Wolbachia‑infected male mosquitoes into three towns showed rapid population suppression of Aedes aegypti—mosquito numbers declined within about four weeks, with one town reaching roughly 95% suppression after a year. The results support Google/Alphabet’s plan to release tens of millions of sterile males in the US and suggest ecological impact would be small, though success hinges on local ecology and ongoing releases, plus strong community engagement. The effort also highlights the value of collaboration across universities and Verily in translating lab concepts to real‑world solutions.
Australian field trials releasing Wolbachia-infected male mosquitoes dramatically reduced Aedes aegypti populations and provided proof-of-principle that large-scale male releases can work with minimal ecological impact, offering important lessons for Google's planned 32 million sterile/incompatible-male releases in California and Florida—emphasizing community engagement, regulatory approvals, and robust sex-separation technology.
San Gabriel Valley Mosquito and Vector Control District is releasing about 480,000 sterile male Aedes aegypti mosquitoes over 16 weeks in a 25-acre Bassett area to prevent wild females from producing offspring, using Wolbachia bacteria; since these are males, they don’t bite, and the program aims to reduce mosquito bites and dengue risk as peak season arrives.
Sacramento’s Rosemont neighborhood kicked off a Sterile Insect Technique program by releasing 144,000 sterile male Aedes aegypti mosquitoes to outcompete wild males and reduce the invasive population, part of a plan to release 2.3 million sterile insects over 16 weeks. The Wolbachia-based approach is environmentally friendly and targets only Aedes aegypti, with previous Natomas pilot showing up to 40% population reduction. The program aims to lower disease risk from dengue, Zika, and chikungunya, while public health officials emphasize the need for residents to drain standing water, use repellents, and report unusual activity. If successful, the program could expand to additional areas.
About 600,000 Wolbachia-infected male mosquitoes are being released around Washington, DC through September to reduce the invasive Asian tiger mosquito, which can spread diseases like West Nile, dengue, Zika and chikungunya. The sterile males mate with biting females, rendering their eggs infertile, which gradually lowers the population. The released mosquitoes don’t bite humans, and this biocontrol program is part of a broader global effort to manage mosquito-borne diseases.
A Maryland company will release about 600,000 Wolbachia-infected, non-biting male Aedes albopictus mosquitoes in the Washington, DC area this summer to reduce local mosquito populations, using an EPA-approved biopesticide approach.
A Silver Spring company, Bee Safe Mosquito Control, will release about 600,000 Wolbachia-infected male mosquitoes (ZAP) in the DC metro area this summer to reduce the Asian tiger mosquito population. These sterile-like males don’t bite; when they mate with females, the females become infertile and eggs won’t hatch. The ZAP males come from MosquitoMate with EPA approval, and the program runs June through September across the DMV for roughly $1,000 per service, which is already sold out for 2026. Alphabet’s Google, via its Debug program, is planning larger-scale Wolbachia releases in California and Florida.”,
Alphabet-backed Verily seeks EPA approval to release 64 million Wolbachia-infected male mosquitoes in California and Florida over two years to reduce disease-carrying populations using the Sterile Insect Technique. The plan, still under EPA review with public comments invited and no approvals yet, has sparked concerns about ecological disruption and transparency, as critics question Google’s role in an outdoor biological experiment and the potential environmental impact.
Google-owned Debug seeks EPA approval to release 32 million Wolbachia-infected male Aedes aegypti mosquitoes in Florida and California to curb disease spread; while the sterile-insect approach has shown promise, critics fear ecological risks and a for-profit company driving environmental interventions, and experts warn of challenges like maintaining sex-sorted releases and avoiding accidental release of females that could undermine the method.
Google, via its Verily life-sciences unit, is seeking EPA approval to release about 64 million Wolbachia-infected sterile male mosquitoes in California and Florida over two years (16 million per state per year) to suppress the Culex quinquefasciatus population and reduce transmission of West Nile virus and St. Louis encephalitis. Males don’t bite, and when they mate with wild females lacking Wolbachia, eggs don’t hatch, lowering mosquito numbers. The initiative uses the suppression method and is not genetically modified. Public comment on the plan is open until June 5; releases have not been mapped to specific counties.